215 related articles for article (PubMed ID: 17133184)
1. Severe stunned myocardium after lightning strike.
Rivera J; Romero KA; González-Chon O; Uruchurtu E; Márquez MF; Guevara M
Crit Care Med; 2007 Jan; 35(1):280-5. PubMed ID: 17133184
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
García González MJ; Domínguez Rodríguez A
Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
[TBL] [Abstract][Full Text] [Related]
3. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
[No Abstract] [Full Text] [Related]
4. Levosimendan in cardiac failure after subarachnoid hemorrhage.
Busani S; Rinaldi L; Severino C; Cobelli M; Pasetto A; Girardis M
J Trauma; 2010 May; 68(5):E108-10. PubMed ID: 20453750
[TBL] [Abstract][Full Text] [Related]
5. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
[TBL] [Abstract][Full Text] [Related]
6. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan: a promising treatment for myocardial stunning?
Ellger BM; Zahn PK; Van Aken HK; Schmidt C; Brussel T
Anaesthesia; 2006 Jan; 61(1):61-3. PubMed ID: 16409345
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
9. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
Vlahović A; Popović A
Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
[TBL] [Abstract][Full Text] [Related]
10. Takotsubo cardiomyopathy following lightning strike.
Dundon BK; Puri R; Leong DP; Worthley MI
Emerg Med J; 2008 Jul; 25(7):460-1. PubMed ID: 18573973
[TBL] [Abstract][Full Text] [Related]
11. Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation.
Summaria F; Mustilli M; Sette A; Lanzillo C; Romagnoli E
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):28-31. PubMed ID: 24492986
[TBL] [Abstract][Full Text] [Related]
12. Effects of postischemic left ventricular pressure-volume unloading on contractile recovery and myocardial blood flow in the regionally stunned canine heart.
Nicolosi AC; Markley JG; Olinger GN
J Thorac Cardiovasc Surg; 1999 Jul; 118(1):181-8. PubMed ID: 10384201
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
14. Myocardial contractile reserve and perfusion defect severity with rest and stress dobutamine (99m)Tc-sestamibi SPECT in canine stunning and subendocardial infarction.
Chin BB; Esposito G; Kraitchman DL
J Nucl Med; 2002 Apr; 43(4):540-50. PubMed ID: 11937600
[TBL] [Abstract][Full Text] [Related]
15. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium.
Sciagrà R; Bisi G; Santoro GM; Rossi V; Fazzini PF
Am J Card Imaging; 1995 Jul; 9(3):157-66. PubMed ID: 7549355
[TBL] [Abstract][Full Text] [Related]
16. The calcium sensitizer levosimendan improves carbon monoxide poisoning related stunned myocardium: a cardiac magnetic resonance study.
Rocco M; Carbone I; Morelli A; Palantonio P; Rossi S; Spadetta G; Passariello R; Pietropaoli P
Acta Anaesthesiol Scand; 2006 Aug; 50(7):897-8. PubMed ID: 16879479
[No Abstract] [Full Text] [Related]
17. Successful use of levosimendan in a patient during cardiopulmonary bypass.
Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
[TBL] [Abstract][Full Text] [Related]
18. Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation.
Taccone FS; Lubicz B; Piagnerelli M; Van Nuffelen M; Vincent JL; De Backer D
Neurocrit Care; 2009; 10(1):76-82. PubMed ID: 18810666
[TBL] [Abstract][Full Text] [Related]
19. Transient ischemic stunning of the myocardium in stress thallium-201 gated SPET myocardial perfusion imaging: segmental analysis of myocardial perfusion, wall motion and wall thickening changes.
Santiago JF; Heiba SI; Jana S; Mirzaitehrane M; Dede F; Abdel-Dayem HM
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):979-83. PubMed ID: 12173009
[TBL] [Abstract][Full Text] [Related]
20. A clinical feature of myocardial stunning associated with acute myocardial infarction.
Sakata K; Yoshida H; Ono N; Matsunaga Y; Hoshino T; Kaburagi T; Mochizuki M; Yoshimura M
Ann Nucl Med; 1994 May; 8(2):153-7. PubMed ID: 8074960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
